COVID-19: Treatment and Recovery Content

‘Monumental Day’ at ��ϲ��Ͽ� Davis Health

Cody Kitaura — December 15, 2020 - 12:37pm

��ϲ��Ͽ� Davis Health today (Dec. 15) began inoculating its frontline health care workers against COVID-19, just hours after the vaccine arrived.

Eva Teniola, a clinical nurse in the emergency department, was the first person at the ��ϲ��Ͽ� Davis Medical Center to receive the historic vaccine produced by Pfizer and BioNTech.

“See, we did it,” she exclaimed, throwing her arms wide with joy after her injection, as other employees broke out into applause around her. The 47-year-old said she signed up to get the vaccine the moment she learned it was going to be available.

��ϲ��Ͽ� Davis Health Joins Novavax in Testing a New COVID-19 Vaccine

Andy Fell — December 07, 2020 - 12:33pm

Despite the encouraging news of potentially successful COVID-19 vaccine trials, there is not yet an FDA-approved vaccine available. Research into other effective coronavirus vaccines continues, including at ��ϲ��Ͽ� Davis Health.

The ICU: Life-Saving Care During COVID-19 and Every Day

Andy Fell — December 07, 2020 - 12:25pm

Hospital Intensive care units, or ICUs, are exactly what they sound like: units that offer intensive patient care. ICU providers specialize in caring for the sickest people and have been critical to saving lives throughout the COVID-19 pandemic — at ��ϲ��Ͽ� Davis Health and across the country.

The Frightening Uncertainty of Long-Haul COVID-19

Dave Jones — December 07, 2020 - 7:21am

In February, when the world barely knew the name COVID-19, Marina Oshana had what she thought was the flu or some other bug.

“I’m an avid Jazzerciser. I love to dance. I was working out five or six days a week,” the ��ϲ��Ͽ� Davis professor emerita of philosophy said on the Dec. 3 edition of ��ϲ��Ͽ� Davis LIVE. “I noticed during the cardio portion of the class, I would get fatigued. It was very strange. It seemed to come on suddenly.”

NIH Grant to Create Humanized Mice Susceptible to COVID-19

Andy Fell — August 03, 2020 - 1:36pm

The National Institutes of Health has awarded a grant of $1.2 million to the Mouse Biology Program at the University of California, Davis, to create mice that are susceptible to the COVID-19 virus, and to distribute them to researchers.

The goal is to create mice that can be used to reproduce human COVID-19 disease, said Kent Lloyd, director of the Mouse Biology Program and professor in the Department of Surgery at the ��ϲ��Ͽ� Davis School of Medicine.

COVID-19 Vaccine With Patch Delivery Technology Enters Preclinical Testing at ��ϲ��Ͽ� Davis

Andy Fell — April 29, 2020 - 4:49pm

Verndari Inc., a biopharmaceutical company, announced today (April 29) that it will begin preclinical testing this week at the University of California, Davis, Mouse Biology Program to evaluate a potential vaccine and delivery system for COVID-19.

��ϲ��Ͽ� Davis Engineers, Clinician Develop Low-Cost, Portable Ventilator

Andy Fell — April 29, 2020 - 4:32pm

Engineers at the University of California, Davis, are working with clinicians to create a simple, inexpensive ventilator. They have developed a prototype and plan to make plans freely available online. Versions could be in clinical use in about six months.

��ϲ��Ͽ� Davis Launches 2 Clinical Studies to Treat COVID-19

Cody Kitaura — March 31, 2020 - 5:00pm

��ϲ��Ͽ� Davis Health has two clinical trials underway for hospitalized patients with severe COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2.

The studies are evaluating the safety and effectiveness of two drugs — the investigational antiviral remdesivir, and sarilumab, a drug that blocks the body’s acute inflammatory response.

��ϲ��Ͽ� Davis Engineers Respond to COVID-19 Challenges

Andy Fell — March 30, 2020 - 2:36pm

Anticipating a scarcity of medical devices and a lack of treatment options for COVID-19, engineering researchers at the University of California, Davis, are investigating innovative technology to manufacture masks, ventilators and other critical equipment.

Wellness Officer Shares Strategies to Cope with COVID-19 Uncertainty

Cody Kitaura — March 12, 2020 - 4:00pm

Peter Yellowlees, chief wellness officer at ��ϲ��Ͽ� Davis Health and a professor in the Department of Psychiatry and Behavioral Sciences, sent this letter to the Sacramento campus today (March 12):

It has been amazing to watch how incredibly professional and caring all ��ϲ��Ͽ� Davis Health staff have been over the past two weeks since the evolution of the COVID-19 outbreak, and our intimate involvement.

COVID-19: Treatment and Recovery Content

‘Monumental Day’ at �������ϲ����Ͽ� Davis Health

�������ϲ����Ͽ� Davis Health Joins Novavax in Testing a New COVID-19 Vaccine